emoxypine succinate has been researched along with Cognition Disorders in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kispaeva, TT | 1 |
| Duma, SN | 1 |
| Shishkova, VN | 2 |
| Kuznetsova, EB; Salina, EA; Sholomov, II | 1 |
| Shmyrev, VI; Sokolova, LP | 1 |
| Alekseev, MI; Koliadich, MI; Rassokhina, LM; Volchegorskiĭ, IA | 1 |
2 review(s) available for emoxypine succinate and Cognition Disorders
| Article | Year |
|---|---|
[Preventive/therapeutic correction of the development and progression of cognitive deficit in patients after stroke].
Topics: Cognition; Cognition Disorders; Disease Progression; Humans; Picolines; Psychotropic Drugs; Stroke; Treatment Outcome | 2013 |
[Specific features of neurological complications developing in patients with type 2 diabetes mellitus and metabolic syndrome: possibility for correction and prevention].
Topics: Antioxidants; Cognition Disorders; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Neuropathies; Endothelium, Vascular; Humans; Metabolic Syndrome; Oxidative Stress; Picolines | 2015 |
2 trial(s) available for emoxypine succinate and Cognition Disorders
| Article | Year |
|---|---|
[Possibilities of antioxidant therapy for asthenia and cognitive deficit in elderly patients with chronic brain ischemia].
Topics: Aged; Antioxidants; Asthenia; Brain Ischemia; Chronic Disease; Cognition Disorders; Female; Humans; Lipoproteins, LDL; Middle Aged; Picolines; Treatment Outcome | 2013 |
[Comparative study of alpha-lipoic acid and mexidol effects on affective status, cognitive functions and quality of life in diabetes mellitus patients].
Topics: Antioxidants; Attention; Cognition; Cognition Disorders; Diabetes Complications; Diabetes Mellitus; Double-Blind Method; Female; Humans; Hyperglycemia; Hyperlipidemias; Hypoglycemic Agents; Lipid Peroxidation; Male; Middle Aged; Picolines; Placebos; Prospective Studies; Psychotropic Drugs; Quality of Life; Russia; Surveys and Questionnaires; Thioctic Acid | 2011 |
3 other study(ies) available for emoxypine succinate and Cognition Disorders
| Article | Year |
|---|---|
[Cognitive impairments as a universal clinical syndrome in a therapist's practice].
Topics: Cognition Disorders; Dementia; Early Diagnosis; Humans; Picolines; Primary Health Care; Prognosis; Psychotropic Drugs | 2014 |
[The possibility of treatment of cognitive impairment in the complex therapy of patients with the consequences of cerebral infarction].
Topics: Aged; Attention; Cerebral Infarction; Cognition; Cognition Disorders; Drug Therapy, Combination; Emotions; Female; Humans; Injections, Intramuscular; Intercellular Signaling Peptides and Proteins; Male; Middle Aged; Neuropsychological Tests; Peptides; Picolines; Quality of Life | 2015 |
[Antioxidant therapy in the treatment of minor and mild (predemential) cognitive impairments of different genesis].
Topics: Adolescent; Adult; Antioxidants; Brain; Brain Mapping; Cognition Disorders; Female; Humans; Male; Middle Aged; Picolines; Positron-Emission Tomography; Young Adult | 2011 |